AI Portfolio Summary
In 2025 Q4, Artia Global Partners LP maintained a portfolio of 75 distinct positions. The most significant new addition to the portfolio was INSMED INC, which now represents 10.36% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing their position by 166.5%. Conversely, Artia Global Partners LP completely exited their position in INSMED INC.
Total Positions
75
Quarter
2025 Q4
Top Holding
INSM (16.8%)
Top 10 Concentration
71.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 75
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INSM
INSMED INC
|
Healthcare | 16.82% | 16.71% |
#1
Prev: #1
|
6.5 | -50,000 | -6.8% |
P
S
|
682,212 | $118,732,177 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 11.48% | 3.03% |
#2
9
Prev: #11
|
8.5 | 375,294 | 166.5% |
P
S
|
600,747 | $81,013,737 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
PUT
INSMED INC
|
Healthcare | 10.36% | — |
#3
Prev: #—
|
8.5 | 420,000 | no change |
NEW
|
420,000 | $73,096,800 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 7.71% | 9.16% |
#4
2
Prev: #2
|
4.1 | -13,612 | -17.4% |
P
S
|
64,699 | $54,408,624 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 7.69% | 3.47% |
#5
4
Prev: #9
|
6.6 | 21,800 | 76.0% |
P
S
|
50,500 | $54,271,340 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 3.59% | 0.61% |
#6
19
Prev: #25
|
4.4 | 573,186 | 392.1% |
P
S
|
719,365 | $25,307,261 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 3.57% | 2.90% |
#7
5
Prev: #12
|
1.9 | 13,900 | 0.7% |
P
S
|
2,013,602 | $25,210,297 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 3.50% | 7.20% |
#8
4
Prev: #4
|
1.4 | -138,478 | -20.6% |
P
S
|
533,698 | $24,710,217 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UGL
PROSHARES TR II
|
ETF | 3.48% | 3.92% |
#9
1
Prev: #8
|
1.9 | -95,253 | -17.7% |
P
S
|
442,119 | $24,546,447 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 3.47% | 6.10% |
#10
4
Prev: #6
|
4.4 | 364,700 | 55.4% |
P
S
|
1,023,539 | $24,493,288 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 2.50% | 0.88% |
#11
8
Prev: #19
|
4.0 | 309,098 | 158.6% |
P
S
|
503,936 | $17,678,075 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AZN
ASTRAZENECA PLC
|
Healthcare | 2.48% | 2.32% |
#12
4
Prev: #16
|
2.0 | no change | no change |
P
S
|
190,752 | $17,535,831 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 2.22% | — |
#13
Prev: #—
|
4.4 | 70,824 | no change |
NEW
|
70,824 | $15,644,313 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EYPT
EYEPOINT PHARMA...
|
Healthcare | 1.99% | 1.42% |
#14
3
Prev: #17
|
3.3 | 138,731 | 22.1% |
P
S
|
767,098 | $14,014,880 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.62% | 0.62% |
#15
9
Prev: #24
|
3.6 | 84,200 | 139.9% |
P
S
|
144,376 | $11,421,585 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.20% | 0.68% |
#16
7
Prev: #23
|
3.5 | 96,367 | 88.6% |
P
S
|
205,090 | $8,451,759 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.18% | 0.77% |
#17
3
Prev: #20
|
1.5 | no change | no change |
P
S
|
104,190 | $8,298,734 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DGX
QUEST DIAGNOSTI...
|
Healthcare | 1.00% | 2.47% |
#18
3
Prev: #15
|
0.4 | -40,900 | -50.1% |
P
S
|
40,817 | $7,082,974 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.98% | 2.50% |
#19
5
Prev: #14
|
0.4 | -17,170 | -49.7% |
P
S
|
17,400 | $6,919,110 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTYX
VENTYX BIOSCIEN...
|
Healthcare | 0.89% | — |
#20
Prev: #—
|
3.9 | 695,982 | no change |
NEW
|
695,982 | $6,284,717 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.88% | — |
#21
Prev: #—
|
3.9 | 59,200 | no change |
NEW
|
59,200 | $6,196,464 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UGL
PUT
PROSHARES TR II
|
ETF | 0.79% | — |
#22
Prev: #—
|
3.8 | 100,000 | no change |
NEW
|
100,000 | $5,552,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.71% | 0.34% |
#23
8
Prev: #31
|
3.3 | 81,200 | 143.5% |
P
S
|
137,800 | $5,000,762 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.70% | — |
#24
Prev: #—
|
3.8 | 119,741 | no change |
NEW
|
119,741 | $4,926,145 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.66% | — |
#25
Prev: #—
|
3.8 | 1,992,367 | no change |
NEW
|
1,992,367 | $4,682,062 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
CALL
INSMED INC
|
CALL Option | 0.00% | 9.13% |
Sold All 😨
(Was: #3) |
0.0 | -400,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRNA
VERONA PHARMA P...
|
Unknown | 0.00% | 6.41% |
Sold All 😨
(Was: #5) |
0.0 | -379,004 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 4.43% |
Sold All 😨
(Was: #7) |
0.0 | -296,750 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.00% | 3.42% |
Sold All 😨
(Was: #10) |
0.0 | -55,100 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.00% | 2.84% |
Sold All 😨
(Was: #13) |
0.0 | -183,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.00% | 0.95% |
Sold All 😨
(Was: #18) |
0.0 | -10,671 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
CALL
ULTRAGENYX PHAR...
|
CALL Option | 0.00% | 0.72% |
Sold All 😨
(Was: #22) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #28) |
0.0 | -57,999 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 0.00% | 0.51% |
Sold All 😨
(Was: #29) |
0.0 | -133,291 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #33) |
0.0 | -54,515 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #34) |
0.0 | -64,502 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IREN
IREN LIMITED
|
Financial Services | 0.00% | 0.25% |
Sold All 😨
(Was: #38) |
0.0 | -33,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #41) |
0.0 | -80,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MREO
MEREO BIOPHARMA...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #44) |
0.0 | -475,361 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
SAREPTA THERAPE...
|
—
|
Unknown | 0.00% | 0.14% |
Sold All 😨
(Was: #45) |
0.0 | -44,900 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MRNA
MODERNA INC
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #47) |
0.0 | -23,800 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #48) |
0.0 | -41,555 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATYR
CALL
ATYR PHARMA INC
|
CALL Option | 0.00% | 0.07% |
Sold All 😨
(Was: #49) |
0.0 | -600,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATYR
ATYR PHARMA INC
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #50) |
0.0 | -372,276 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #51) |
0.0 | -71,029 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 75 holdings